Prime Capital Investment Advisors, LLC Viking Therapeutics, Inc. Transaction History
Prime Capital Investment Advisors, LLC
- $6.88 Billion
- Q3 2024
A detailed history of Prime Capital Investment Advisors, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 3,719 shares of VKTX stock, worth $173,677. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,719Holding current value
$173,677% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
474Shares Held
66.2MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$475 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$281 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$218 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$98.8 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$87.6 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.58B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...